PE-backed Patheon files for IPO

Durham, North Carolina-based Patheon, a provider of outsourced pharmaceutical development and manufacturing services, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. J.P. Morgan, Morgan Stanley, Jefferies and UBS are serving as the lead underwriters. Patheon is owned by JLL Partners and Royal DSM.

Zeus Capital promotes Allen to research head

Zeus Capital has promoted Mike Allen to head of research. Prior to joining Zeus, Allen worked at Panmure Gordon, UBS and Numis Securities. Allen first joined Zeus Capital as a research director in September 2014.

Evercore taps Calvert as MD

Evercore has named Lea Lazaric Calvert as a managing director for the firm’s private capital advisory business. Calvert’s appointment begins in July. Previously, she worked at UBS where she served as an executive director and was a member of the company’s private funds group.


Noah Keys joins AlpInvest as a principal

AlpInvest Partners, The Carlyle Group‘s private equity fund of funds, recently named Noah Keys as a principal, according to a spokesperson at Carlyle. In his new position, Keys will be responsible for secondaries and co-investments in the energy, infrastructure and natural resources industries.
Previously, Keys served as an executive director in UBS Investment Bank’s global energy group.


Apax to buy Azelis

3i has agreed to sell Atlas Holding SA, the holding company of the Azelis Group, to Apax Partners. Financial terms weren’t announced. Azelis is a pan-European speciality chemical distributor. 3i acquired a majority of Azelis in 2007. JP Morgan is providing financing. UBS acted as financial advisor to the Apax funds while Greenhill acted as financial advisor to 3i.


Pritzker Group Private Capital hires Blackstone, TPG, UBS execs

Pritzker Group Private Capital has hired three professionals to its Los Angeles office. The new Los Angeles team includes former Blackstone Group managing director Michael Dal Bello as an investment partner on the healthcare investment team. Dal Bello is joined by Ceron Rhee as vice president in healthcare, a former vice president at TPG Capital; and Evan Earley, associate, who joins from UBS, where he worked as an analyst.


TPG invests in CAA

TPG has acquired a majority stake in Los Angeles-based Creative Artists Agency, which represents top entertainment and sports professionals. No financial terms were disclosed. UBS and LionTree Advisors provided financial advice to CAA in the transaction.


Permira inks $3.51 bln sale of Arysta LifeScience

Platform Specialty Products Corp. said Monday it has agreed to buy Arysta LifeScience for about $3.51 billion. Arysta, a crop protection and life science companies, is backed by Permira. Permira is expected to receive about $2.91 billion in cash and a $600 million in a preferred note in Platform. Credit Suisse, Barclays, UBS Investment Bank and Nomura Securities International acted as M&A advisors to Platform. Credit Suisse, UBS Investment Bank, and Nomura have committed financing for the acquisition. Morgan Stanley and J.P. Morgan provided financial advice to Permira.

PE HUB Community

Join the 12519 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget